Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Cabozantinib in ovarian clear cell cancers: UnMET expectations.

Publication ,  Journal Article
Secord, AA; Previs, RA; Nixon, AB
Published in: Gynecol Oncol
July 2018

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Gynecol Oncol

DOI

EISSN

1095-6859

Publication Date

July 2018

Volume

150

Issue

1

Start / End Page

1 / 2

Location

United States

Related Subject Headings

  • Receptor Protein-Tyrosine Kinases
  • Pyridines
  • Ovarian Neoplasms
  • Oncology & Carcinogenesis
  • Humans
  • Female
  • Anilides
  • Adenocarcinoma, Clear Cell
  • 3215 Reproductive medicine
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Secord, A. A., Previs, R. A., & Nixon, A. B. (2018). Cabozantinib in ovarian clear cell cancers: UnMET expectations. Gynecol Oncol, 150(1), 1–2. https://doi.org/10.1016/j.ygyno.2018.06.006
Secord, Angeles Alvarez, Rebecca A. Previs, and Andrew B. Nixon. “Cabozantinib in ovarian clear cell cancers: UnMET expectations.Gynecol Oncol 150, no. 1 (July 2018): 1–2. https://doi.org/10.1016/j.ygyno.2018.06.006.
Secord AA, Previs RA, Nixon AB. Cabozantinib in ovarian clear cell cancers: UnMET expectations. Gynecol Oncol. 2018 Jul;150(1):1–2.
Secord, Angeles Alvarez, et al. “Cabozantinib in ovarian clear cell cancers: UnMET expectations.Gynecol Oncol, vol. 150, no. 1, July 2018, pp. 1–2. Pubmed, doi:10.1016/j.ygyno.2018.06.006.
Secord AA, Previs RA, Nixon AB. Cabozantinib in ovarian clear cell cancers: UnMET expectations. Gynecol Oncol. 2018 Jul;150(1):1–2.
Journal cover image

Published In

Gynecol Oncol

DOI

EISSN

1095-6859

Publication Date

July 2018

Volume

150

Issue

1

Start / End Page

1 / 2

Location

United States

Related Subject Headings

  • Receptor Protein-Tyrosine Kinases
  • Pyridines
  • Ovarian Neoplasms
  • Oncology & Carcinogenesis
  • Humans
  • Female
  • Anilides
  • Adenocarcinoma, Clear Cell
  • 3215 Reproductive medicine
  • 3211 Oncology and carcinogenesis